Journal of Renal Nutrition
Volume 15, Issue 1 , Pages 131-136 , January 2005

Adipose tissue and its relation to inflammation: The role of adipokines

  • Jonas Axelsson, MD

      Affiliations

    • Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    • ,
  • Olof Heimbürger, MD, PhD

      Affiliations

    • Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    • ,
  • Bengt Lindholm, MD, PhD

      Affiliations

    • Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    • ,
  • Peter Stenvinkel, MD, PhD

      Affiliations

    • Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
    • Corresponding Author InformationAddress reprint requests to Peter Stenvinkel, MD, PhD, Department of Renal Medicine, K56, Karolinska University Hospital at Huddinge, 141 86 Stockholm, Sweden.

References 

  1. Stenvinkel P . Inflammatory and atherosclerotic interactions in the depleted uremic patient . Blood Purif . 2001;19:53–61
  2. Stenvinkel P , Heimbürger O , Lindholm B , et al.   Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome) . Nephrol Dial Transplant . 2000;15:953–960
  3. Nawrocki A , Scherer PE . The delicate balance between fat and muscle (Adipokines in metabolic disease and musculoskeletal inflammation) . Curr Opin Pharmacol . 2004;4:281–289
  4. Fleischmann E , Teal N , Dudley J , et al.   Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients . Kidney Int . 1999;55:1560–1567
  5. Kopple JD , Zhu X , Lew NL , et al.   Body weight-for-height relationships predict mortality and morbidity in maintenance hemodialysis patients . Kidney Int . 1999;56:1136–1148
  6. Port FK , Ashby VB , Dhingra RK , et al.   Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients . J Am Soc Nephrol . 2002;13:1061–1066
  7. Stenvinkel P , Heimburger O , Lindholm B . Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease . Nephrol Dial Transplant . 2004;19: 2181–2123
  8. Morabia A , Ross A , Curtin F , et al.   Relation of BMI to a dual-energy X-ray absorptiometry measure of fatness . Br J Nutr . 1999;82:49–55
  9. Beddhu S , Pappas LM , Ramkumar N , et al.   Effects of body size and body composition on survival in hemodialysis patients . J Am Soc Nephrol . 2003;14:2366–2372
  10. Kershaw EE , Flier JS . Adipose tissue as an endocrine organ . J Clin Endocrinol Metab . 2004;89:2548–2556
  11. Kalantar-Zadeh K , Block G , Humphreys MH , et al.   Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients . Kidney Int . 2003;63:793–808
  12. Keith DS , Nichols GA , Gullion CM , et al.   Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization . Arch Intern Med . 2004;164:659–663
  13. Mohamed-Ali V , Goodrick S , Rawesh A , et al.   Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-α, in vivo . J Clin Endocrinol Metab . 1997;82:4196–4200
  14. Wellen KE , Hotamisligil GS . Obesity-induced inflammatory changes in adipose tissue . J Clin Invest . 2003;112:1785–1788
  15. Pedersen M , Bruunsgaard H , Weis N , et al.   Circulating levels of TNF-alpha and IL-6—-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes . Mech Ageing Dev . 2003;124:495–502
  16. Esposito K , Pontillo A , Di Palo C , et al.   Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women (A randomized trial) . JAMA . 2003;289:1799–1804
  17. Arner P . The adipocyte in insulin resistance (Key molecules and the impact of the thiazolidinediones) . Trends Endocrinol Metab . 2003;14:137–145
  18. Atzmon G , Yang XM , Muzumdar R , et al.   Differential gene expression between visceral and subcutaneous fat depots . Horm Metab Res . 2002;34:622–628
  19. Fried SK , Bunkin DA , Greenberg AS . Omental and subcutaneous adipose tissue of obese subjects release interleukin-6 (Depot difference and regulation by glucocorticoid) . J Clin Endocrinol Metab . 1998;83:847–850
  20. Axelsson J , Qureshi AR , Suliman ME , et al.   Truncal fat mass as a contributor to inflammation in end-stage renal disease . Am J Clin Nutr . 2004;80:1222–1229
  21. Nordfors L , Lönnqvist F , Heimbürger O , et al.   Low leptin gene expression and hyperleptinemia in chronic renal failure . Kidney Int . 1998;54:1267–1275
  22. Kielstein JT , Becker B , Graf S , et al.   Increased resistin blood levels are not associated with insulin resistance in patients with renal disease . Am J Kidney Dis . 2003;42:62–66
  23. Pecoits-Filho R , Heimbürger O , Barany P , et al.   Associations between circulating inflammatory markers and residual renal function in CRF patients . Am J Kidney Dis . 2003;41:1212–1218
  24. Stenvinkel P , Pecoits-Filho R , Lindholm B . Leptin, ghrelin and proinflammatory cytokines (Compounds with nutritional impact in chronic kidney disease) . Adv Ren Replace Ther . 2003;10:332–345
  25. Banks WA , Coon AB , Robinson SM , et al.   Triglycerides induce leptin resistance at the blood-brain barrier . Diabetes . 2004;53:1253–1260
  26. Pajvani UB , Hawkins M , Combs TP , et al.   Complex distribution, not absolute amount of adiponectin, correlates with thiazolidedione-mediated improvement in insulin sensitivity . J Biol Chem . 2004;279:12152–12162
  27. Hotta K , Funahashi T , Arita Y , et al.   Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients . Arterioscler Thromb Vasc Biol . 2000;20:1595–1599
  28. Spranger J , Kroke A , Mohlig M , et al.   Adiponectin and protection against type-2 diabetes mellitus . Lancet . 2003;361:226–228
  29. Rajala MW , Scherer PE . Minireview (The adipocyte—At the crossroads of energy homeostasis, inflammation, and atherosclerosis) . Endocrinology . 2003;144:3765–3773
  30. Ouchi N , Ohishi M , Kihara S , et al.   Association of hypoadiponectinemia with impaired vasoreactivity . Hypertension . 2003;42:231–234
  31. Zoccali F , Mallamaci F , Tripepi G , et al.   Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease . J Am Soc Nephrol . 2002;13:134–141
  32. Stenvinkel P , Marchlewska A , Pecoits-Filho R , et al.   Adiponectin in renal disease (relationship to phenotype and genetic variation in the gene encoding adiponectin) . Kidney Int . 2003;65:274–281
  33. Okamoto Y , Kihara S , Ouchi N , et al.   Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice . Circulation . 2002;106:2767–2770
  34. Ouchi N , Kihara S , Arita Y , et al.   Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signalling through a cAMP-dependent pathway . Circulation . 2000;102:1296–1301
  35. Ouchi N , Kihara S , Funahashi T , et al.   Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue . Circulation . 2003;107:671–674
  36. Rea R , Donnelly R . Resistin: An adipocyte-derived hormone. Has it a role in diabetes and obesity? . Diabetes Obes Metab . 2004;6:163–170
  37. Steppan CM , Bailey ST , Bhat S , et al.   The hormone resistin links obesity to diabetes . Nature . 2001;409:307–312
  38. Kawanami D , Maemura K , Takeda N , et al.   Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells (A new insight into adipocytokine-endothelial cell interactions) . Biochem Biophys Res Commun . 2004;314:415–419
  39. Patel L , Buckels AC , Kinghorn IJ , et al.   Resistin is expressed in human macrophages and directly regulated by PPARγ activators . Biochem Biophys Res Commun . 2003;300:472–476
  40. Stenvinkel P , Ketteler M , Johnson RJ , et al.   Interleukin-10, IL-6 and TNF-α (important factors in the altered cytokine network of end-stage renal disease—The good, the bad and the ugly) . Kidney Int . 2005; (in press)
  41. Kaizu Y , Ohkawa S , Odamaki M , et al.   Association between inflammatory mediators and muscle mass in long-term hemodialysis patients . Am J Kidney Dis . 2003;42:295–302
  42. Visser M , Bouter LM , McQuillan GM , et al.   Elevated C-reactive protein levels in overweight and obese adults . JAMA . 1999;282:2131–2135
  43. Ferrucci L , Penninx BW , Volpato S , et al.   Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels . J Am Geriatr Soc . 2002;50:1947–1954
  44. Yeh SS , Schuster MW . Geriatric cachexia (The role of cytokines) . Am J Clin Nutr . 1999;70:183–197
  45. Cederholm T , Wretlind B , Hellstrom K , et al.   Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease . Am J Clin Nutr . 1997;65:876–882
  46. Tsujinaka T , Fujita J , Ebisuri C , et al.   Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin-6 transgenic mice . J Clin Invest . 1996;97:244–249
  47. Barbieri M , Ferruci L , Ragno E , et al.   Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons . Am J Physiol Endocrinol Metab . 2003;284:E481–E487

 Supported in part by grants from Karolinska Institutets Fund for Gender-Based Research (PS), and Söderbergs Foundation (PS).

PII: S1051-2276(04)00240-7

doi: 10.1053/j.jrn.2004.09.034

Journal of Renal Nutrition
Volume 15, Issue 1 , Pages 131-136 , January 2005

Article Tools

* Image Usage & Resolution